Cargando…
The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
AIM: This study aimed to compare the effect of the same volume of moderate- and high-intensity aerobic exercise on patients' liver steatosis and fibrosis. BACKGROUND: Exercise is known strategy to deal with non-alcoholic fatty liver disease (NAFLD). METHODS: This Randomized Control Trial was pe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105501/ https://www.ncbi.nlm.nih.gov/pubmed/37070113 http://dx.doi.org/10.22037/ghfbb.v16i1.2466 |
_version_ | 1785026222009352192 |
---|---|
author | Hassabi, Mohammad Sadeghi, Amir Abedy Yekta, Amir Hosein Salehi, Shahin Mahdaviani, Behnaz Asgari, Ahmadreza Poursaeid Esfahani, Mehrshad |
author_facet | Hassabi, Mohammad Sadeghi, Amir Abedy Yekta, Amir Hosein Salehi, Shahin Mahdaviani, Behnaz Asgari, Ahmadreza Poursaeid Esfahani, Mehrshad |
author_sort | Hassabi, Mohammad |
collection | PubMed |
description | AIM: This study aimed to compare the effect of the same volume of moderate- and high-intensity aerobic exercise on patients' liver steatosis and fibrosis. BACKGROUND: Exercise is known strategy to deal with non-alcoholic fatty liver disease (NAFLD). METHODS: This Randomized Control Trial was performed on 60 patients randomly assigned to three arms of the study (1:1:1). Fibrosis and steatosis of liver including Control Attenuated Parameter (CAP) determined using Transient Elastography (TE). The control group was advised to adjust their lifestyle, as a routine management. The intervention groups additionally, participated on supervised exercise programs with two different intensities but the same volume of 1000 KCal per week. The intensities of 50% and 70% of V02 reserve were considered for moderate-intensity and vigorous programs, respectively. RESULTS: On six-month follow-up, none of outcomes were statistically significant among three arms of study. However, changes in some outcomes were reached to statistically significant difference in follow-up in comparison with baseline. The mean of CAP score changes was -19.43 (31.43) (P=0.03), 9.92 (26.81) (P=0.21), and 14.61 (18.03) (P=0.01) in control, moderate- and high-intensity groups, respectively. In the high-intensity group, in addition to steatosis, this difference was also observed in the rate of fibrosis. Besides, the level of serum aminotransferases in the group with moderate exercise after six months had a significant decrease compared to baseline. (P=0.01) CONCLUSION: Improvement in steatosis and fibrosis was more evident in high- intensity group. As the rate of drop out was high, caution is needed in interpretation of the results. |
format | Online Article Text |
id | pubmed-10105501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-101055012023-04-16 The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial Hassabi, Mohammad Sadeghi, Amir Abedy Yekta, Amir Hosein Salehi, Shahin Mahdaviani, Behnaz Asgari, Ahmadreza Poursaeid Esfahani, Mehrshad Gastroenterol Hepatol Bed Bench Original Article AIM: This study aimed to compare the effect of the same volume of moderate- and high-intensity aerobic exercise on patients' liver steatosis and fibrosis. BACKGROUND: Exercise is known strategy to deal with non-alcoholic fatty liver disease (NAFLD). METHODS: This Randomized Control Trial was performed on 60 patients randomly assigned to three arms of the study (1:1:1). Fibrosis and steatosis of liver including Control Attenuated Parameter (CAP) determined using Transient Elastography (TE). The control group was advised to adjust their lifestyle, as a routine management. The intervention groups additionally, participated on supervised exercise programs with two different intensities but the same volume of 1000 KCal per week. The intensities of 50% and 70% of V02 reserve were considered for moderate-intensity and vigorous programs, respectively. RESULTS: On six-month follow-up, none of outcomes were statistically significant among three arms of study. However, changes in some outcomes were reached to statistically significant difference in follow-up in comparison with baseline. The mean of CAP score changes was -19.43 (31.43) (P=0.03), 9.92 (26.81) (P=0.21), and 14.61 (18.03) (P=0.01) in control, moderate- and high-intensity groups, respectively. In the high-intensity group, in addition to steatosis, this difference was also observed in the rate of fibrosis. Besides, the level of serum aminotransferases in the group with moderate exercise after six months had a significant decrease compared to baseline. (P=0.01) CONCLUSION: Improvement in steatosis and fibrosis was more evident in high- intensity group. As the rate of drop out was high, caution is needed in interpretation of the results. Shaheed Beheshti University of Medical Sciences 2023 /pmc/articles/PMC10105501/ /pubmed/37070113 http://dx.doi.org/10.22037/ghfbb.v16i1.2466 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits others to copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Original Article Hassabi, Mohammad Sadeghi, Amir Abedy Yekta, Amir Hosein Salehi, Shahin Mahdaviani, Behnaz Asgari, Ahmadreza Poursaeid Esfahani, Mehrshad The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
title | The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
title_full | The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
title_fullStr | The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
title_full_unstemmed | The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
title_short | The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
title_sort | role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105501/ https://www.ncbi.nlm.nih.gov/pubmed/37070113 http://dx.doi.org/10.22037/ghfbb.v16i1.2466 |
work_keys_str_mv | AT hassabimohammad theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT sadeghiamir theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT abedyyektaamirhosein theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT salehishahin theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT mahdavianibehnaz theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT asgariahmadreza theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT poursaeidesfahanimehrshad theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT hassabimohammad roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT sadeghiamir roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT abedyyektaamirhosein roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT salehishahin roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT mahdavianibehnaz roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT asgariahmadreza roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial AT poursaeidesfahanimehrshad roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial |